PDC*line Pharma Shares Phase I/II Data On Cancer Vaccine At ESMO-IO
12 Dec 2024 //
BUSINESSWIRE
AACR 2024: PDC*line Pharma Presents Interim Clinical Data
08 Apr 2024 //
BUSINESSWIRE
PDC*line Presents Results From Phase I/II Trial With PDC*lung01
08 Dec 2022 //
BUSINESSWIRE
PDC*line Pharma Raises €17.5 Million in Series B2 Financing Round
06 Dec 2021 //
BUSINESSWIRE